Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Kissei Pharmaceutical Co. Ltd. (4547)
Market Open
12 Jun, 06:00
JPX
All
(2)
JP
(1)
US
(1)
JPX
Primary
OTC PINK
¥
3,920.
00
+45
+1.1613%
¥
194.62B
Market Cap
-
P/E Ratio
1.26%
Div Yield
3,600
Volume
-
Eps
¥
3,875
Previous Close
Watching
Watch
Add Transaction
Day Range
3,875
3,945
Year Range
3,500
5,040
Want to track
4547
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Statistics
Historical Data
Kissei Pharmaceutical Co. Ltd. (4547) Statistics
Valuation metrics
Market Cap
194.62B
Enterprise value
129.71B
Trailing P/E (ttm)
11.42
Forward P/E
21.98
PEG ratio
0.55
Price/Sales (ttm)
1.62
Price/Book (mrq)
0.68
Enterprise Value/Revenue
1.33
Enterprise Value/EBITDA
6.82
Overview
Shares outstanding
41.45M
Float
27.96M
Shares short
-
% Held by insiders
0.23%
% Held by institutions
0.23%
Average volume (10 days)
126.08K
Average volume (90 days)
112.79K
Price summary
52-Week low
3,500
52-Week high
5,040
Beta
-0.13
50-Day moving average
4,195.78
200-Day moving average
4,539.77
Dividends and splits
Forward annual dividend rate
200
Forward annual dividend yield
0.042%
Trailing annual dividend rate
160
Trailing annual dividend yield
0.0421%
5-Year annual dividend yield
2.46%
Payout ratio
0.34
Dividend Date
1 Dec 2025
Ex-Dividend Date
29 Sep 2025
Last split factor
-
Last split Date
-
Financials
Fiscal year
Fiscal year ends
31 Mar 2025
Most recent quarter (mrq)
30 Jun 2025
Profitability
Profit margin
0.14%
Operating margin
-0.03%
Operational effectiveness
Return on assets
0.05%
Return on equity
0.06%
Income Statement
Revenue (ttm)
95.29B
Revenue per share (ttm)
2,351.84
Quarterly revenue growth (yoy)
0.15%
Gross profit (ttm)
45.94B
EBITDA
11.64B
Net income to common (ttm)
14.14B
Diluted EPS (ttm)
332.67
Quarterly earnings growth (yoy)
-0.1%
Balance Sheet
Total cash (mrq)
46.73B
Total cash per share (mrq)
1,314.05
Total debt (mrq)
1.27B
Total Debt/Equity (mrq)
0.01
Current ratio (mrq)
5.3%
Book value per share (mrq)
5,590.39
Cash Flow
Cash flow statement
13.94B
Levered free cash flow (LFCF)
11.96B